One in 5 parents of boys said the main reason that they haven’t vaccinated their sons for HPV was because they didn’t receive a recommendation for the vaccination, compared with 1 in 10 girls, said Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
One in 5 parents of boys said the main reason that they haven’t vaccinated their sons for HPV was because they didn’t receive a recommendation for the vaccination, compared with 1 in 10 girls, said Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
Transcript
What gender differences have you identified in HPV vaccination?
We did the study because we know boys are less likely to get vaccinated with the HPV vaccination compared to girls in the United States, although both are actually lagging behind the recommended vaccination rates in other westernized nations and the goal for the United States. Mainly we saw that for both, lack of necessity was a common reason as well as lack of knowledge about the vaccine.
Broken down by gender, where we saw the big differences, where that parents of boys much more commonly reported that lack of recommendation from a physician was the biggest driver. One in 5 parents of boys says the main reason that they haven’t vaccinated was because they didn’t receive a recommendation for the vaccination, compared to 1 in 10 girls. We also saw that parents of girls were more likely to report concerns about safety and side effects and a concern that their child wasn’t sexually active yet as their main reason for lack of vaccination compared to boys.
What interventions are needed to close this gap between genders?
I think the biggest intervention that providers — and that includes nurses, advanced practitioners, such as physician assistants and nurse practitioners, as well as physicians – can really do is provide a strong, clear recommendation that the vaccine provides cancer prevention, and it’s not just for girls, it’s also for boys. It is effective against cancers that affect both genders as well as cancers that specifically affect girls and women.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More